Jun 12, 2023 / 11:00PM GMT
Corinne Jenkins - Goldman Sachs Group, Inc., Research Division - VP
Well, great. Thanks so much for joining us today. We have Gritstone bio and Celia here to join us, who's the CFO for the company.
Questions and Answers:
Corinne Jenkins - Goldman Sachs Group, Inc., Research Division - VPAnd maybe Celia, you could just start with like a brief overview, particularly focused on what you see as key value drivers for the company for the next 12 to 24 months.
Vassiliki Economides - Gritstone bio, Inc. - Executive VP & CFO
Of course. Well, it's good to be here, Corinne, in such a packed room at the end of the day, tons and tons of people in here. Thank you for the invitation, first and foremost. We're pleased to be here after quite a few years of not really having this conference. So Gritstone is in a pretty amazing spot right now. We have a pretty major catalyst that's coming up in Q1 of next year for our lead program, GRANITE, which is a personalized neoantigen-based cancer vaccine. We've been hearing a lot
Trustpilot
